StartupsFinSMEsabout 14 hours ago
RQ Bio Raises £85.5M in Series A Funding
1 min read
RQ Bio raised £85.5 million in Series A funding. The round supports the company's work on developing broad-spectrum antiviral therapies. RQ Bio focuses on creating treatments effective against multiple virus families.
Level
Hype check
Tap to vote and see what everyone thinks.
